241 related articles for article (PubMed ID: 15226322)
21. Radiotherapy concurrent with weekly gemcitabine after transurethral tumor resection in muscle ınvasive bladder cancer.
Demirci U; Dızdar O; Cetindag MF; Altınova S; Ozsavran A; Dede DS; Kızılırmak N; Eraslan FA; Yalcın B; Cinkir HY
J Cancer Res Ther; 2015; 11(4):704-7. PubMed ID: 26881505
[TBL] [Abstract][Full Text] [Related]
22. Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer.
Blackstock AW; Bernard SA; Richards F; Eagle KS; Case LD; Poole ME; Savage PD; Tepper JE
J Clin Oncol; 1999 Jul; 17(7):2208-12. PubMed ID: 10561277
[TBL] [Abstract][Full Text] [Related]
23. Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer.
Trodella L; Granone P; Valente S; Turriziani A; Macis G; Corbo GM; Margaritora S; Cesario A; D'Angelillo RM; Gualano G; Ramella S; Galetta D; Cellini N
J Clin Oncol; 2002 Feb; 20(3):804-10. PubMed ID: 11821464
[TBL] [Abstract][Full Text] [Related]
24. Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study.
Gagel B; Piroth M; Pinkawa M; Reinartz P; Krohn T; Kaiser HJ; Stanzel S; Breuer C; Asadpour B; Schmachtenberg A; Eble MJ
BMC Cancer; 2007 Jun; 7():112. PubMed ID: 17598906
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.
Allen AM; Zalupski MM; Robertson JM; Eckhauser FE; Simone D; Brown D; Hejna G; Normolle D; Lawrence TS; McGinn CJ
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1461-7. PubMed ID: 15275733
[TBL] [Abstract][Full Text] [Related]
26. Incidental surgical findings of a phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with unresectable non-small cell lung cancer.
Cesario A; Margaritora S; Trodella L; Valente S; Corbo GM; Macis G; Galetta D; d'Angelillo RM; Porziella V; Ramella S; Mangiacotti MG; Granone P
Lung Cancer; 2002 Aug; 37(2):207-12. PubMed ID: 12140144
[TBL] [Abstract][Full Text] [Related]
27. Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial.
Coen JJ; Zhang P; Saylor PJ; Lee CT; Wu CL; Parker W; Lautenschlaeger T; Zietman AL; Efstathiou JA; Jani AB; Kucuk O; Souhami L; Rodgers JP; Sandler HM; Shipley WU
J Clin Oncol; 2019 Jan; 37(1):44-51. PubMed ID: 30433852
[TBL] [Abstract][Full Text] [Related]
28. Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study.
Eisbruch A; Shewach DS; Bradford CR; Littles JF; Teknos TN; Chepeha DB; Marentette LJ; Terrell JE; Hogikyan ND; Dawson LA; Urba S; Wolf GT; Lawrence TS
J Clin Oncol; 2001 Feb; 19(3):792-9. PubMed ID: 11157033
[TBL] [Abstract][Full Text] [Related]
29. A phase I dose escalation trial of gemcitabine with radiotherapy for breast cancer in the treatment of unresectable chest wall recurrences.
Suh WW; Schott AF; Hayman JA; Schipper MJ; Shewach DS; Pierce LJ
Breast J; 2004; 10(3):204-10. PubMed ID: 15125746
[TBL] [Abstract][Full Text] [Related]
30. Phase I study of conformal radiotherapy and concurrent full-dose gemcitabine with erlotinib for unresected pancreatic cancer.
Robertson JM; Margolis J; Jury RP; Balaraman S; Cotant MB; Ballouz S; Boxwala IG; Jaiyesimi IA; Nadeau L; Hardy-Carlson M; Marvin KS; Wallace M; Ye H
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e187-92. PubMed ID: 21549514
[TBL] [Abstract][Full Text] [Related]
31. The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer.
Asadauskiene J; Aleknavicius E; Pipiriene-Zelviene T; Jankevicius F
Medicina (Kaunas); 2010; 46(5):305-14. PubMed ID: 20679745
[TBL] [Abstract][Full Text] [Related]
32. A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma.
Duffy A; Kortmansky J; Schwartz GK; Capanu M; Puleio S; Minsky B; Saltz L; Kelsen DP; O'Reilly EM
Ann Oncol; 2008 Jan; 19(1):86-91. PubMed ID: 17878176
[TBL] [Abstract][Full Text] [Related]
33. Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I study.
Mohiuddin M; Kudrimoti M; Regine WF; McGrath PC; Hanna N; John W
Cancer J; 2002; 8(3):255-62. PubMed ID: 12074325
[TBL] [Abstract][Full Text] [Related]
34. Intravesical gemcitabine for non-muscle invasive bladder cancer.
Jones G; Cleves A; Wilt TJ; Mason M; Kynaston HG; Shelley M
Cochrane Database Syst Rev; 2012 Jan; 1():CD009294. PubMed ID: 22259002
[TBL] [Abstract][Full Text] [Related]
35. Phase I study of twice-weekly gemcitabine and concurrent thoracic radiation for patients with locally advanced non-small-cell lung cancer.
Blackstock AW; Lesser GJ; Fletcher-Steede J; Case LD; Tucker RW; Russo SM; White DR; Miller A
Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1281-9. PubMed ID: 11728688
[TBL] [Abstract][Full Text] [Related]
36. Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study.
Brade A; Brierley J; Oza A; Gallinger S; Cummings B; Maclean M; Pond GR; Hedley D; Wong S; Townsley C; Brezden-Masley C; Moore M
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1027-36. PubMed ID: 17197132
[TBL] [Abstract][Full Text] [Related]
37. Phase I study of radiochemotherapy with gemcitabine in invasive bladder cancer.
Borut K; Lijana ZK
Radiother Oncol; 2012 Mar; 102(3):412-5. PubMed ID: 21890225
[TBL] [Abstract][Full Text] [Related]
38. Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder.
Dalbagni G; Russo P; Sheinfeld J; Mazumdar M; Tong W; Rabbani F; Donat MS; Herr HW; Sogani P; dePalma D; Bajorin D
J Clin Oncol; 2002 Aug; 20(15):3193-8. PubMed ID: 12149290
[TBL] [Abstract][Full Text] [Related]
39. Gemcitabine modulation of alkylator therapy: a phase I trial of escalating gemcitabine added to fixed doses of ifosfamide and doxorubicin.
Millikan RE; Plunkett WK; Smith TL; Williams DL; Logothetis CJ
Cancer; 2001 Jul; 92(1):194-9. PubMed ID: 11443627
[TBL] [Abstract][Full Text] [Related]
40. Gemcitabine, paclitaxel, and radiation for locally advanced pancreatic cancer: a Phase I trial.
Safran H; Dipetrillo T; Iannitti D; Quirk D; Akerman P; Cruff D; Cioffi W; Shah S; Ramdin N; Rich T
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):137-41. PubMed ID: 12182983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
